Evidence map›Paper›PMID 39040610›Full record

ArticleCureus2024

Complex Factors in Hydrocephalus Development in Tuberous Sclerosis Complex: A Case Report of Subependymal Giant Cell Astrocytoma.

Hajime Nakamura, Masaki Izumi, Yoshinori Omori, Shingo Numoto, Ayataka Fujimoto

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hajime NakamuraNeurosurgery, Seirei Hamamatsu General Hospital, Hamamatsu, JPN.
Masaki IzumiCenter of Epilepsy and Functional Neurology, Seirei Hamamatsu General Hospital, Hamamatsu, JPN.
Yoshinori OmoriCenter of Epilepsy and Functional Neurology, Seirei Hamamatsu General Hospital, Hamamatsu, JPN.
Shingo NumotoPediatric Neurology, Seirei Hamamatsu General Hospital, Hamamatsu, JPN.
Ayataka FujimotoCenter of Epilepsy and Functional Neurology, Seirei Hamamatsu General Hospital, Hamamatsu, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) occurs in 5-20% of TSC patients, with a subset developing hydrocephalus. We present a case of a 14-year-old male diagnosed with TSC in the neonatal period who developed SEGA and subsequent hydrocephalus. Despite reducing the tumor size with the mammalian target of rapamycin (mTOR) inhibitors, ventricular enlargement persisted, indicating that obstructive hydrocephalus due to the foramen of Monro blockage was not the sole mechanism. Elevated cerebrospinal fluid (CSF) protein levels suggested additional factors like impaired CSF outflow. This case underscores the need for comprehensive treatment strategies and further research to better understand and manage hydrocephalus in TSC patients with SEGA.

Indexed as

hydrocephalusmammalian target of rapamycin (mtor) inhibitorsubependymal giant cell astrocytoma (sega)surgical removaltuberous sclerosis complex (tsc)

Identifiers

PMID39040610
PMCPMC11262810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.